Cargando…
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
INTRODUCTION: To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to investigate their prevalence and prognostic significance. A possible correlation between MET receptor expression, MET gene alterations and the two...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526580/ https://www.ncbi.nlm.nih.gov/pubmed/28742836 http://dx.doi.org/10.1371/journal.pone.0181527 |
_version_ | 1783252833140736000 |
---|---|
author | Al-Saad, Samer Richardsen, Elin Kilvaer, Thomas K. Donnem, Tom Andersen, Sigve Khanehkenari, Mehrdad Bremnes, Roy M. Busund, Lill-Tove |
author_facet | Al-Saad, Samer Richardsen, Elin Kilvaer, Thomas K. Donnem, Tom Andersen, Sigve Khanehkenari, Mehrdad Bremnes, Roy M. Busund, Lill-Tove |
author_sort | Al-Saad, Samer |
collection | PubMed |
description | INTRODUCTION: To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to investigate their prevalence and prognostic significance. A possible correlation between MET receptor expression, MET gene alterations and the two most frequent occurring EGFR gene mutations was also investigated. MATERIALS AND METHODS: Stage I to IIIA tumors from 326 patients with NSCLC were immunohistochemically tested for protein expression of MET and IGF-1. Their cytoplasmic expression was compared with the gene copy number of the MET and IGF1Rgenes by SISH in paraffin-embedded, formalin-fixed material. Correlations were made with the immunohistochemical expression of two frequent EGFR mutations and clinicopathological variables. Univariate and multivariate survival analyses was used to evaluate the prognostic efficacy of the tested markers. RESULTS: In univariate analyses, high cytoplasmic MET expression showed a significant negative prognostic effect in adenocarcinoma patients (p = 0.026). MET gene to chromosome 7 ratio was a significant positive prognostic marker (p = 0.005), probably only due to the highly negative prognostic significance of chromosome 7 polysomy (p = 0.002). High IGF1R gene copy number was a negative prognostic marker for all NSCLC patients (p = 0.037). In the multivariate analysis, polysomy of chromosome 7 in tumor cells correlated significantly and independently with a poor prognosis (p = 0.011). In patients with adenocarcinoma, a high cytoplasmic MET expression was an independent negative prognostic marker (p = 0.013). In males a high IGF1R gene copy number to chromosome 15 count ratio was significantly and independently correlated to a poor prognosis (p = 0.018). CONCLUSION: MET protein expression provides superior prognostic information compared with SISH. Polysomy of chromosome 7 is an independent negative prognostic factor in NSCLC patients. This finding has an important implication while examining genes located on chromosome 7 by means of SISH. High IGF1R gene copy number to chromosome 15 count ratio is an independent predictor of inferior survival in male patients with primary NSCLC. |
format | Online Article Text |
id | pubmed-5526580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55265802017-08-07 The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer Al-Saad, Samer Richardsen, Elin Kilvaer, Thomas K. Donnem, Tom Andersen, Sigve Khanehkenari, Mehrdad Bremnes, Roy M. Busund, Lill-Tove PLoS One Research Article INTRODUCTION: To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to investigate their prevalence and prognostic significance. A possible correlation between MET receptor expression, MET gene alterations and the two most frequent occurring EGFR gene mutations was also investigated. MATERIALS AND METHODS: Stage I to IIIA tumors from 326 patients with NSCLC were immunohistochemically tested for protein expression of MET and IGF-1. Their cytoplasmic expression was compared with the gene copy number of the MET and IGF1Rgenes by SISH in paraffin-embedded, formalin-fixed material. Correlations were made with the immunohistochemical expression of two frequent EGFR mutations and clinicopathological variables. Univariate and multivariate survival analyses was used to evaluate the prognostic efficacy of the tested markers. RESULTS: In univariate analyses, high cytoplasmic MET expression showed a significant negative prognostic effect in adenocarcinoma patients (p = 0.026). MET gene to chromosome 7 ratio was a significant positive prognostic marker (p = 0.005), probably only due to the highly negative prognostic significance of chromosome 7 polysomy (p = 0.002). High IGF1R gene copy number was a negative prognostic marker for all NSCLC patients (p = 0.037). In the multivariate analysis, polysomy of chromosome 7 in tumor cells correlated significantly and independently with a poor prognosis (p = 0.011). In patients with adenocarcinoma, a high cytoplasmic MET expression was an independent negative prognostic marker (p = 0.013). In males a high IGF1R gene copy number to chromosome 15 count ratio was significantly and independently correlated to a poor prognosis (p = 0.018). CONCLUSION: MET protein expression provides superior prognostic information compared with SISH. Polysomy of chromosome 7 is an independent negative prognostic factor in NSCLC patients. This finding has an important implication while examining genes located on chromosome 7 by means of SISH. High IGF1R gene copy number to chromosome 15 count ratio is an independent predictor of inferior survival in male patients with primary NSCLC. Public Library of Science 2017-07-25 /pmc/articles/PMC5526580/ /pubmed/28742836 http://dx.doi.org/10.1371/journal.pone.0181527 Text en © 2017 Al-Saad et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Al-Saad, Samer Richardsen, Elin Kilvaer, Thomas K. Donnem, Tom Andersen, Sigve Khanehkenari, Mehrdad Bremnes, Roy M. Busund, Lill-Tove The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer |
title | The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer |
title_full | The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer |
title_fullStr | The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer |
title_full_unstemmed | The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer |
title_short | The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer |
title_sort | impact of met, igf-1, igf1r expression and egfr mutations on survival of patients with non-small-cell lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526580/ https://www.ncbi.nlm.nih.gov/pubmed/28742836 http://dx.doi.org/10.1371/journal.pone.0181527 |
work_keys_str_mv | AT alsaadsamer theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT richardsenelin theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT kilvaerthomask theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT donnemtom theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT andersensigve theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT khanehkenarimehrdad theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT bremnesroym theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT busundlilltove theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT alsaadsamer impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT richardsenelin impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT kilvaerthomask impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT donnemtom impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT andersensigve impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT khanehkenarimehrdad impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT bremnesroym impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer AT busundlilltove impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer |